Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Cancer|January 19, 2018
Early and Partial Reduction in CD4+Foxp3+ Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4+ and CD8+ T Cell Activation Inhibiting TumorigenesisJonadab E Olguín, Itzel Medina-Andrade, Emmanuel Molina, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|April 28, 2016
Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer modelIsmael M Urrutia-Ortega, Luis G Garduño-Balderas, Norma L Delgado-Buenrostro, et al.
International Journal of Biological Sciences|November 24, 2011
Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammationGiuliana López-Navarrete, Espiridión Ramos-Martínez, Karina Suárez-Álvarez, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2024
Helminth-derived molecules improve 5-fluorouracil treatment on experimental colon tumorigenesisMónica G Mendoza-Rodríguez, Daniela Medina-Reyes, Cuauhtémoc A Sánchez-Barrera, et al.
International Journal of Cancer|August 14, 2019
Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-κB and STAT3 regulationBlanca E Callejas, Mónica G Mendoza-Rodríguez, Olga Villamar-Cruz, et al.
International Journal of Molecular Sciences|April 5, 2020
Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated TumorigenesisMónica G Mendoza-Rodríguez, C Ángel Sánchez-Barrera, Blanca E Callejas, et al.
Cancer Immunology Research|April 8, 2017
Lack of STAT6 Attenuates Inflammation and Drives Protection against Early Steps of Colitis-Associated Colon CancerSonia A Leon-Cabrera, Emmanuel Molina-Guzman, Yael G Delgado-Ramirez, et al.
International Journal of Molecular Sciences|February 11, 2023
Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative TherapiesAntonio Andrade-Meza, Luis E Arias-Romero, Leonel Armas-López, et al.
Pageof 9